trccregistry.org

TRRI, or the TFE Renal Cell Carcinoma Research Initiatives, is a global consortium dedicated to advancing the understanding and treatment of TFE renal cell carcinomas (TFE RCC). Comprising a network of leading physicians and researchers, TRRI focuses on collecting essential clinical data and biological samples from both pediatric and adult patient populations. This collaborative effort aims to fill critical gaps in existing knowledge and enhance treatment outcomes for patients afflicted by TFE RCC.

The organization is actively involved in several key initiatives, including the establishment of a comprehensive registry that characterizes the clinical behavior and treatment of TFE RCC, the development of innovative tumor models for cancer research, and drug discovery efforts aimed at identifying new therapeutic options. Through educational resources and supportive services for patients and families, TRRI is committed to promoting awareness and fostering research that ultimately benefits those impacted by this complex disease. For inquiries and support, TRRI encourages individuals to reach out directly via phone or email.